ABEC, Inc. (ABEC) is a leader in biopharma manufacturing solutions, investing significantly in research and development to advance innovations in the field. To protect these investments, the Company maintains a comprehensive global intellectual property portfolio directed to its technologies, products, processes, platforms, and related innovations.

This page is provided for general informational and notice purposes, identifying selected issued patents and published patent applications within ABEC’s portfolio. The inclusion or omission of any patent or published patent application does not constitute a waiver, disclaimer, or limitation of any intellectual property rights owned, licensed, or otherwise controlled by the Company.

No license or other right—express or implied—under any patent, trademark, copyright, trade secret, or other intellectual property right is granted by the publication of this information. Furthermore, the inclusion of any patent or published patent application identified on this page does not constitute an admission regarding ownership, enforceability, claim scope, validity, or applicability to any specific product, process, service, or activity.